Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-β1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C

作者: Robert Flisiak

DOI: 10.3748/WJG.V11.I43.6833

关键词: PharmacologyRibavirinTransforming growth factor betaMetalloproteinaseAlpha interferonMedicineHepatitis CRecombinant DNATransforming growth factorMetalloproteinase Inhibitor 1Virology

摘要: Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-β1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C

参考文章(34)
Robert Flisiak, Anatol Panasiuk, Danuta Prokopowicz, Peter M Timms, Paul Maxwell, Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis. Hepato-gastroenterology. ,vol. 49, pp. 1369- 1372 ,(2002)
Kevin Michael Walsh, Peter Timms, Stewart Campbell, Ronald Norman, Maciver Macsween, Allan John Morris, Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis. Digestive Diseases and Sciences. ,vol. 44, pp. 624- 630 ,(1999) , 10.1023/A:1026630129025
Yoshikazu Murawaki, Yujito Ikuta, Youko Idobe, Hironaka Kawasaki, Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis. Journal of Gastroenterology and Hepatology. ,vol. 14, pp. 138- 145 ,(2002) , 10.1046/J.1440-1746.1999.01821.X
S. Kanzler, M. Baumann, P. Schirmacher, V. Dries, E. Bayer, G. Gerken, H.-P. Dienes, A. W. Lohse, Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. Journal of Viral Hepatitis. ,vol. 8, pp. 430- 437 ,(2001) , 10.1046/J.1365-2893.2001.00314.X
Thomas Knittel, Mirko Mehde, Dominik Kobold, Bernhard Saile, Christina Dinter, Giuliano Ramadori, Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1 Journal of Hepatology. ,vol. 30, pp. 48- 60 ,(1999) , 10.1016/S0168-8278(99)80007-5
Toshiaki Ninomiya, Seitetsu Yoon, Hidenobu Nagano, Yoshiko Kumon, Yasushi Seo, Masato Kasuga, Yoshihiko Yano, Miyuki Nakaji, Yoshitake Hayashi, Significance of Serum Matrix Metalloproteinases and Their Inhibitors on the Antifibrogenetic Effect of Interferon-Alfa in Chronic Hepatitis C Patients Intervirology. ,vol. 44, pp. 227- 231 ,(2001) , 10.1159/000050052
Manuela G Neuman, Jean-Pierre Benhamou, Marc Bourliere, Asma Ibrahim, Izabella Malkiewicz, Tarik Asselah, Michelle Martinot-Peignoux, Neil H Shear, Gady G Katz, Raoudha Akremi, Souad Benali, Nathalie Boyer, Laurence Lecomte, Veronique Le Breton, Gaelle Le Guludec, Patrick Marcellin, SERUM TUMOUR NECROSIS FACTOR-α AND TRANSFORMING GROWTH FACTOR-β LEVELS IN CHRONIC HEPATITIS C PATIENTS ARE IMMUNOMODULATED BY THERAPY Cytokine. ,vol. 17, pp. 108- 117 ,(2002) , 10.1006/CYTO.2001.0997
Hiroyoshi Taniguchi, Naoya Kato, Motoyuki Otsuka, Tadashi Goto, Hideo Yoshida, Yasushi Shiratori, Masao Omata, Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. Journal of Medical Virology. ,vol. 72, pp. 52- 59 ,(2004) , 10.1002/JMV.10545
David J Grainger, David E Mosedale, James C Metcalfe, TGF-β in blood: a complex problem Cytokine & Growth Factor Reviews. ,vol. 11, pp. 133- 145 ,(2000) , 10.1016/S1359-6101(99)00037-4
D E Clouthier, S A Comerford, R E Hammer, Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. Journal of Clinical Investigation. ,vol. 100, pp. 2697- 2713 ,(1997) , 10.1172/JCI119815